Recombinant Human Erythropoietin: A Review of Pharmacology and Therapeutic Potential in AnemiasEpoetin alfa (EPO) is a biosynthetic form of the glycoprotein hormone. Erythropoietin has been shown to be highly effective in prevention of anemia, i.e anemia due to renal failure, anemia of AIDS...
Recombinant human epoetin alfa, HX575, is the first biosimilar erythropoiesis-stimulating agent (ESA) with European marketing authorisation. The primary objective of this double-blind, randomised, multicentre study was to assess the efficacy and safety of HX575 in treating chemotherapy-associated symptoma...
erythropoietinwestern blottingELISAEprex®Aranesp®Mircera®The recombinant human erythropoietins epoetin alfa (Eprex®), darbepoetin (Aranesp®) and methoxy polyethylene glycol-epoetin beta (Mircera®) were administered to greyhounds for 7, 10 and 14 days respectively. Blood and urine samples...
Recombinant human erythropoietins (rhEPO) reliably increase hemoglobin levels in cancer patients experiencing chemotherapy-associated anemia. However, in patients with “anemia of cancer” not being treated with chemotherapy, rhEPO appears less effective. Recently, two studies have been broadly discussed whi...
Recombinant human erythropoietin (rhEPO) and darbepoetin alfa (DPO) are protein-based drugs for the treatment of anemia in humans by stimulating erythrocyt... F Guan,CE Uboh,LR Soma,... - 《Analytical Chemistry》 被引量: 123发表: 2008年 Selective glycopeptide mapping of erythropoietin by on-...
BACKGROUND: Recombinant human epoetin alfa, HX575, is the first biosimilar erythropoiesis-stimulating agent (ESA) with European marketing authorisation. The primary objective of this double-blind, randomised, multicentre study was to assess the efficacy and safety of HX575 in treating chemotherapy-assoc...
Summary Over the past decade an increasing number of studies have supported the use of recombinant human erythropoietin (epoetin) in cancer patients, suggesting that it improves haemoglobin concentrations for some. There is also evidence that this treatment may lead to improvement in quality of life ...
Arizona, Tucson, Arizona; 2Department of Family and Community Medicine, University of Arizona, Tucson, Arizona; 3Matrix45, Tucson, Arizona, USAAbstract: Since the expiration of the patent for epoetin alfa in Europe in 2004, the European Medicines Agency has approved three biosimilar erythropoietins...
上海玉博生物科技有限公司 主要致力于“Recombinant Rat Erythropoietin R&D-1306-RE-010”的生产销售。多年的“Recombinant Rat Erythropoietin R&D-1306-RE-010”生产与销售的经验,与各行业新老用户建立了稳定的合作关系,我公司经营的产品名称深受广大用户信赖。欢迎来
PRS-cyt-201-1mg Recombinant Human Erythropoietin-alpha EPOA 1mg 21735 PRS-cyt-201-50ug Recombinant Human Erythropoietin-alpha EPOA 50ug 2080 PRS-cyt-201-5ug Recombinant Human Erythropoietin-alpha EPOA 5ug 800 PRS-cyt-202-0.5mg Recombinant Human Growth Hormone GH 0.5mg 2080 ...